ESCP Highlights 2017

Written by Alex Burton | 21 Oct 2017 | All Medical News

ESCP 2017 delegates give their highlights, plus a report on the ESCP/ECCO symposium on ulcerative colitis and a focus on quality of life for patients with perianal Crohn’s disease.

Watch the video above for highlights from Professor Jared Torkington (University Hospital of Wales, Cardiff), Mr Samuel Adegbola (St Mark’s Hospital, London) and Professor Martin Kreis (Charité University Medical Centre, Berlin).

ESCP Highlights 2017

Latest Stories

Liminal BioSciences announces FDA approval for its BLA of Ryplazim to treat patients with plasminogen deficiency type 1

Simple diagnostic tool predicts individual risk of Alzheimer’s

Janssen presents results of first head-to-head study of biologic therapies in patients with moderate to severe Crohn’s disease

Testosterone therapy may reduce non-alcoholic fatty liver disease in obese

ESCP Highlights 2017

Latest Stories

Liminal BioSciences announces FDA approval for its BLA of Ryplazim to treat patients with plasminogen deficiency type 1

Simple diagnostic tool predicts individual risk of Alzheimer’s

Janssen presents results of first head-to-head study of biologic therapies in patients with moderate to severe Crohn’s disease

Testosterone therapy may reduce non-alcoholic fatty liver disease in obese

Register for our mailing list

Follow Us